[CLDX] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
12-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 3.11%
YoY- -57.57%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 236 2,728 887 546 715 1,425 1,764 -73.87%
PBT -11,259 -12,625 -10,447 -11,413 -11,779 -17,239 -9,402 12.78%
Tax -228 -16 -4,448 -5,090 -2,990 5,234 -8,746 -91.22%
NP -11,031 -12,625 -10,447 -11,413 -11,779 -17,239 -9,402 11.25%
Tax Rate - - - - - - - -
Total Cost 11,267 15,353 11,334 11,959 12,494 18,664 11,166 0.60%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin -4,674.15 -462.79 -1,177.79 -2,090.29 -1,647.41 -1,209.75 -532.99 325.82%
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS -0.50 -0.73 -0.64 -0.75 -0.84 -1.40 -0.81 -27.52%
EPS Diluted -0.50 -0.73 -0.64 -0.75 -0.84 -1.40 -0.81 -27.52%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.